Northwestern is one of several medical schools in the country who have mandated a disclosure of faculty relationships with drug and device makers, including ownership interests, service on corporate board and consulting fees, according to the report.
All relationships are now disclosed on the school’s Web site on each faculty member’s profile.
The school’s dean said in a statement that such relationships are necessary to advance science to benefit patients but that the school recognizes the importance of avoiding potential conflicts of interest, according to the report.
Read Crain’s Chicago Business’s report on Northwestern Feinberg’s faculty disclosures.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
